Gallbladder motility in Crohn disease: influence of disease localization and bowel resection.
BACKGROUND
Patients with Crohn disease (CD) have an increased risk of developing gallstones. Among other factors, gallbladder motility may have a role in the pathogenesis of gallstone formation. We have evaluated whether gallbladder motor function is affected in Crohn disease with special emphasis on the influence of disease localization and previous bowel resection.


METHODS
Thirty-seven patients (20 females and 17 males, age 36 +/- 2 years) with inactive Crohn disease (CDAI < 150) were studied: 15 patients after ileocecal resection and 22 non-operated patients; 12 had small bowel disease and 10 had large bowel disease. Nineteen healthy subjects (10 female; 9 male, age 30 +/- 2 years) served as controls. Gallbladder volumes were measured in the fasting state and at regular intervals for 2 h after ingestion of a solid meal (780 kcal). Blood samples were drawn at regular intervals for determination of cholecystokinin (CCK) and peptide YY (PYY).


RESULTS
Fasting gallbladder volumes were significantly (P < 0.05) reduced in patients with large bowel disease (20.8 +/- 2.1 ml) or after ileocecal resection (18.3 +/- 2.4 ml) compared to patients with small bowel disease (28.0 +/- 2.1 ml) and controls (27.2 +/- 1.8 ml). Fasting plasma CCK levels were significantly (P < 0.05) higher in patients with large bowel disease or after ileocecal resection compared to patients with small bowel disease and controls. Postprandial gallbladder emptying and endogenous plasma CCK and PYY secretion in patients with Crohn disease were not different from controls.


CONCLUSIONS
Fasting gallbladder volume is decreased and fasting plasma CCK levels are increased in patients with Crohn disease of the large bowel and patients after ileocecal resection. Postprandial gallbladder motility, CCK and PYY release were not affected in patients with Crohn disease.
Vu
M K
MK
Dept. of Gastroenterology-Hepatology, Leiden University Medical Center, The Netherlands.
Gielkens
H A
HA
van Hogezand
R A
RA
van Oostayen
J A
JA
Lamers
C B
CB
Masclee
A A
AA
D000328:Adult; D002432:Cecum / Q000601:surgery*; D002766:Cholecystokinin / Q000097:blood; D003106:Colon / Q000473:pathology; D003424:Crohn Disease / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery; D005260:Female; D016473:Gallbladder Emptying; D006801:Humans; D007082:Ileum / Q000473:pathology / Q000601:surgery*; D008297:Male; D010191:Pancreatic Polypeptide / Q000097:blood; D019894:Peptide YY / Q000097:blood
D019894:Peptide YY; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin